Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1436 participants.

Also called NCT05846893

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,436 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05846893
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Malaysia, Singapore, South Korea, Taiwan (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05846893. Randomized; no masking; primary purpose treatment. Start 2023-09-07 (actual); primary completion 2027-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
Acronym
REVERSE
Condition
Myocardial Ischemia
Condition
Acute Coronary Syndrome
Condition
Coronary Stenosis
Condition
De Novo Stenosis
Intervention (Device)
SeQuent® Please NEO drug-coated balloon catheter
Intervention (Device)
Current-generation drug-eluting stent
Lead sponsor
B. Braun Medical Industries Sdn. Bhd. (class: industry)
Collaborator
B. Braun Melsungen AG (class: industry)
Collaborator
Ulsan University Hospital (class: other)
Collaborator
European Cardiovascular Research Center (class: research network)
Collaborator
Seoul National University Hospital (class: other)
Collaborator
Universität des Saarlandes (class: other)

Record details

Record id
cardio:ct-nct05846893
Content hash
fdcba0b17acb9dfaebcda4c539cdeeb75e585e6da7c1de133d2c781cfd5fd286